Search - tctmd.com

Displaying 81 - 100 of 620

Sort: Relevancy | Date

TCTMD’s Top 10 Most Popular Stories for May 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2024

May 31, 2024

Thrombectomy’s Benefits in Large-Core Strokes Sustained at 1 Year: TENSION

News Conference News ESOC 2024

Thrombectomy’s Benefits in Large-Core Strokes Sustained at 1 Year: TENSION

May 22, 2024

LASTE Shows Thrombectomy Helps for Large Strokes of All Sizes

News Daily News

LASTE Shows Thrombectomy Helps for Large Strokes of All Sizes

May 10, 2024

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

News Conference News SCAI 2024

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

May 10, 2024

May 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

May 01, 2024

TCTMD’s Top 10 Most Popular Stories for April 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2024

April 30, 2024

FDA Approves Bioresorbable Scaffold for BTK Lesions

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

News Daily News

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

April 24, 2024

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

News Conference News ACC 2024

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

April 16, 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

April 10, 2024

TCTMD’s Top 10 Most Popular Stories for March 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2024

April 03, 2024

TCTMD’s Top 10 Most Popular Stories for February 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2024

March 01, 2024

Mechanism’s Mojo ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

MOST: Eptifibatide, Argatroban Don’t Improve on IV Thrombolysis Alone

News Conference News ISC 2024

MOST: Eptifibatide, Argatroban Don’t Improve on IV Thrombolysis Alone

February 08, 2024

ZODIAC: Laying Flat Equals Better Outcomes for Stroke Thrombectomy Candidates

News Conference News ISC 2024

ZODIAC: Laying Flat Equals Better Outcomes for Stroke Thrombectomy Candidates

February 08, 2024

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

News Daily News

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

Michael O'Riordan

February 07, 2024

AI Tools to Meet Every Need? The Future of Vascular Medicine

News Conference News ISET 2024

AI Tools to Meet Every Need? The Future of Vascular Medicine

February 02, 2024

TCTMD’s Top 10 Most Popular Stories for January 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2024

February 01, 2024

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

News Conference News ISET 2024

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

January 31, 2024

AI in Pulmonary Embolism: ‘Transformative’ for Patient Care

News Conference News ISET 2024

AI in Pulmonary Embolism: ‘Transformative’ for Patient Care

January 30, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.